<DOC>
	<DOCNO>NCT02602938</DOCNO>
	<brief_summary>The purpose study determine whether Aspirin could affect number subtype circulate tumor cell metastatic breast cancer colorectal cancer .</brief_summary>
	<brief_title>Aspirin CTCs Advanced Breast Colorectal Cancer</brief_title>
	<detailed_description>BACKGROUND : - Invasion metastasis main reason death metastatic cancer , abundant evidence find circulate tumor cell ( CTCs ) take core position breast colorectal cancer metastasis . - Platelets play multiple role facilitate epithelial mesenchymal transition tumor cell protect CTCs survival circulation , enrol whole process metastasis . - Several clinical trial observational study validate primary secondary prevention effect aspirin breast colorectal cancer . OBJECTIVES : - Determine effect aspirin CTC number metastatic breast colorectal cancer ; - Determine effect aspirin CTC subtype ( epithelial/mesenchymal/mixed type ) metastatic breast colorectal cancer . ELIGIBILITY : - Adults age 18-75 year old . - Patients diagnose metastatic breast colorectal cancer pathology . - Patients currently receive intravenous chemotherapy , oral administrate capecitabine permit . Concurrent endocrine therapy ( least 2 month enrollment ) , bisphosphonate therapy , and/or monoclonal target therapy permit . - No disease hemorrhagic tendency history non-steroid drug allergy . - CTCs≥5 / 7.5ml blood STUDY DESIGN : - Aspirin administer orally day 28-day cycle . - The CTC evaluate every 28 day 2 month .</detailed_description>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Adults age 1875 year old . Patients diagnose metastatic breast colorectal cancer pathology . Patients currently receive intravenous chemotherapy , oral administrate capecitabine permit . Concurrent endocrine therapy ( least 2 month enrollment ) , bisphosphonate therapy , and/or monoclonal target therapy permit . PS score ≤ 3 Anticipated survival time ≥ 3 month CTCs≥5 / 7.5ml blood Allergic aspirin type nonsteroid History hemorrhage digestive tract hemorrhagic disease Plan receive surgery within time frame trial Medication history aspirin type antiplatelets drug within one month trial Women pregnant lactation period Any psychological objective problem may influence compliance patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>aspirin</keyword>
	<keyword>circulate tumor cell</keyword>
	<keyword>metastatic breast cancer</keyword>
	<keyword>metastatic colorectal cancer</keyword>
</DOC>